Novo Nordisk And Eli Lilly Will Mint Money Soon

Elon Musk revealed that he achieved his "fit, ripped, and healthy" physique through fasting and the weight-loss drug Wegovy. Wegovy (semaglutide), will sell $3bn-4bn of it in America alone this year. The firm plans to launch the drug in many more countries in the coming months. Its share price is up by 40% over the past year and has doubled over the past two. Eli Lilly, another pharmaceutical firm, hopes to start selling a similar treatment for obesity, called Mounjaro (tirzepatide), as early as this summer.



Like
Comment
Share

Comments

Post a Comment

Popular posts from this blog

Surprises that could affect commodity markets in 2024

Russia is pounding Kyiv non-stop, Western sanctions are beginning to cripple Arctic LNG  2, Russia’s largest gas-export project. Red Sea, through  which 10% of the world’s seaborne oil travels, American forces are doing their worst to repel drone attacks by Yemen’s Houthi rebels. Local protests are shutting down production at crucial Libyan oilfields. Severe drought in the Amazon will hamper maize shipments from Brazil, the world’s largest exporter of the grain.
Read more